|
1
|
Raptopoulos V: Peritoneal mesothelioma.
Crit Rev Diagn Imaging. 24:293–328. 1985.PubMed/NCBI
|
|
2
|
Cunha P, Luz Z, Seves I, Sousa C, Skiappa,
Ribeiro L, Marques C and Oliveira M: Malignant peritoneal
mesothelioma-diagnostic and therapeutic difficulties. Acta Med
Port. 15:383–386. 2002.(In Portuguese). PubMed/NCBI
|
|
3
|
Ahmed I, Tipu Ahmed S and Ishtiaq S:
Malignant mesothelioma. Pak J Med Sci. 29:1433–1438.
2013.PubMed/NCBI
|
|
4
|
Røe OD and Stella GM: Malignant pleural
mesothelioma: History, controversy and future of a manmade
epidemic. Eur Respir Rev. 24:115–131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mirabelli D, Roberti S, Gangemi M, Rosato
R, Ricceri F, Merler E, Gennaro V, Mangone L, Gorini G, Pascucci C,
et al: Survival of peritoneal malignant mesothelioma in Italy: A
population-based study. Int J Cancer. 124:194–200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rudd RM: Malignant mesothelioma. Br Med
Bull. 93:105–123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Robinson BW and Lake RA: Advances in
malignant mesothelioma. N Engl J Med. 353:1591–1603. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kondola S, Manners D and Nowak AK:
Malignant pleural mesothelioma: An update on diagnosis and
treatment options. Ther Adv Respir Dis. 10:275–288. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coulie PG, Brichard V, Van Pel A, Wölfel
T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C,
Szikora JP, et al: A new gene coding for a differentiation antigen
recognized by autologous cytolytic T lymphocytes on HLA-A2
melanomas. J Exp Med. 180:35–42. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Labrecque S, Naor N, Thomson D and
Matlashewski G: Analysis of the anti-p53 antibody response in
cancer patients. Cancer Res. 53:3468–3471. 1993.PubMed/NCBI
|
|
11
|
Disis ML, Calenoff E, McLaughlin G, Murphy
AE, Chen W, Groner B, Jeschke M, Lydon N, McGlynn E, Livingston RB,
et al: Existent T-cell and antibody immunity to HER-2/neu protein
in patients with breast cancer. Cancer Res. 54:16–20.
1994.PubMed/NCBI
|
|
12
|
Boon T, Coulie PG and Van den Eynde B:
Tumor antigens recognized by T cells. Immunol Today. 18:267–268.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen YT, Güre AO, Tsang S, Stockert E,
Jäger E, Knuth A and Old LJ: Identification of multiple
cancer/testis antigens by allogeneic antibody screening of a
melanoma cell line library. Proc Natl Acad Sci USA. 95:6919–6923.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van der Bruggen P, Traversari C, Chomez P,
Lurquin C, De Plaen E, Van den Eynde BJ, Knuth A and Boon T: A gene
encoding an antigen recognized by cytolytic T lymphocytes on a
human melanoma. J Immunol. 178:2617–2621. 2007.PubMed/NCBI
|
|
15
|
Caballero OL and Chen YT: Cancer/testis
(CT) antigens: Potential targets for immunotherapy. Cancer Sci.
100:2014–2021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sahin U, Türeci O, Schmitt H, Cochlovius
B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and
Pfreundschuh M: Human neoplasms elicit multiple specific immune
responses in the autologous host. Proc Natl Acad Sci USA.
92:11810–11813. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Türeci O, Sahin U, Zwick C, Koslowski M,
Seitz G and Pfreundschuh M: Identification of a meiosis-specific
protein as a member of the class of cancer/testis antigens. Proc
Natl Acad Sci USA. 95:5211–5216. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen YT, Scanlan MJ, Sahin U, Türeci O,
Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M and Old
LJ: A testicular antigen aberrantly expressed in human cancers
detected by autologous antibody screening. Proc Natl Acad Sci USA.
94:1914–1918. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee SY, Obata Y, Yoshida M, Stockert E,
Williamson B, Jungbluth AA, Chen YT, Old LJ and Scanlan MJ:
Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA.
100:2651–2656. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song MH, Ha JM, Shin DH, Lee CH, Old L and
Lee SY: KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis
antigen in colon cancer. Int J Oncol. 41:1820–1826. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suri A, Jagadish N, Saini S and Gupta N:
Targeting cancer testis antigens for biomarkers and immunotherapy
in colorectal cancer: Current status and challenges. World J
Gastrointest Oncol. 7:492–502. 2015.PubMed/NCBI
|
|
22
|
Grah JJ, Katalinic D, Juretic A, Santek F
and Samarzija M: Clinical significance of immunohistochemical
expression of cancer/testis tumor-associated antigens (MAGE-A1,
MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Tumori. 100:60–68. 2014.PubMed/NCBI
|
|
23
|
Sigalotti L, Coral S, Altomonte M, Natali
L, Gaudino G, Cacciotti P, Libener R, Colizzi F, Vianale G, Martini
F, et al: Cancer testis antigens expression in mesothelioma: Role
of DNA methylation and bioimmunotherapeutic implications. Br J
Cancer. 86:979–982. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gaykalova DA, Vatapalli R, Wei Y, Tsai HL,
Wang H, Zhang C, Hennessey PT, Guo T, Tan M, Li R, et al: Outlier
analysis defines zinc finger gene family DNA methylation in tumors
and saliva of head and neck cancer patients. PLoS One.
10:e01421482015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hentati A, Bejaoui K, Pericak-Vance MA,
Hentati F, Speer MC, Hung WY, Figlewicz DA, Haines J, Rimmler J,
Ben Hamida C, et al: Linkage of recessive familial amyotrophic
lateral sclerosis to chromosome 2q33-q35. Nat Genet. 7:425–428.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kiyokawa H and Ray D: In vivo roles of
CDC25 phosphatases: Biological insight into the anti-cancer
therapeutic targets. Anticancer Agents Med Chem. 8:832–836. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Galaktionov K, Lee AK, Eckstein J, Draetta
G, Meckler J, Loda M and Beach D: CDC25 phosphatases as potential
human oncogenes. Science. 269:1575–1577. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kristjánsdóttir K and Rudolph J: Cdc25
phosphatases and cancer. Chem Biol. 11:1043–1051. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim J, Singh AK, Takata Y, Lin K, Shen J,
Lu Y, Kerenyi MA, Orkin SH and Chen T: LSD1 is essential for oocyte
meiotic progression by regulating CDC25B expression in mice. Nat
Commun. 6:101162015. View Article : Google Scholar : PubMed/NCBI
|
